IP Verse

Use Of Hif Alpha Stabilizers For Enhancing Erythropoiesis

PatentPatent Analysis

EP2322153

FIBROGEN
Application Number
EP10182213A
Filing Date
Jun 4, 2004
Status
Revoked
Jun 10, 2022
Grant Date
Oct 8, 2014
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2298301B2
EP3470397B1
EP3003284B1

Bibliography

The patent EP2322153B1 was granted to Fibrogen on Oct 8, 2014 following the initial filing on Jun 4, 2004 under the application number EP10182213A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GLAXOSMITHKLINE UKJun 26, 2019WITHDRAWN
BAYER GMBHBAYER PHARMA AKTIENGESELLSCHAFTBAYER ANIMAL HEALTHJul 8, 2015WITHDRAWN
AKEBIA THERAPEUTICSJul 6, 2015ADMISSIBLE
GLAXO GROUPJul 6, 2015WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents